# Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

> **NCT02664883** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Southern California** · enrollment: 37 (actual)

## Conditions studied

- Healthy Subject
- Metastatic Renal Cell Cancer
- Recurrent Renal Cell Carcinoma
- Stage I Renal Cell Cancer
- Stage II Renal Cell Cancer
- Stage III Renal Cell Cancer

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Cytology Specimen Collection Procedure
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT02664883
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-09-08
- **Primary completion:** 2022-04-13
- **Final completion:** 2026-10-29
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2026-04-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02664883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02664883, "Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02664883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*